A. ARSB activity increases between days 5 and 30 (p<0.001, one-way ANOVA with Tukey-Kramer post-test) in the oil control, but is significantly less in the estrogen-treated prostate tissue (p<0.001).
B. GALNS activity increases significantly between days 5 and 30 in both the control and estrogen-treated prostate tissue (p<0.001), and is significantly greater on day 30 following estrogen (p<0.01).
C. Steroid sulfatase activity is stable between days 5 and 30 for both control and estrogen-treated tissue, but is significantly less following exogenous estrogen (p<0.001).
[Statistical test is one-way ANOVA with Tukey-Kramer post-test. N for controls is 6 and for estrogen-treated is 6 for each time point. ARSB=arylsulfatase B; GALNS=Galactose-6-sulfatase; STS=steroid sulfatase]